Andhra Pradesh, India

Srinivas Reddy Sanikommu

This inventor holds 1 USPTO granted patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivas Reddy Sanikommu. Retrieved from https://idiyas.com/inventor/srinivas-reddy-sanikommu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Srinivas Reddy Sanikommu

Introduction

Srinivas Reddy Sanikommu is a notable inventor hailing from Andhra Pradesh, India. With a keen focus on pharmaceuticals, he has made significant strides in the field of medicinal chemistry.

Latest Patents

Srinivas holds a patent for a groundbreaking process for the preparation of rivaroxaban. This innovative method not only addresses the synthesis of rivaroxaban but also emphasizes purification techniques, reflecting his expertise in pharmaceutical development.

Career Highlights

Currently, Srinivas is associated with Glenmark Pharmaceuticals Limited, where he contributes his skills to the development of advanced pharmaceutical solutions. His work involves enhancing drug formulations and improving processes that benefit the healthcare sector.

Collaborations

Throughout his career, Srinivas has worked alongside esteemed colleagues, including Shrikant Prabhakar Keshav and Sanjay Shashikant Bhise. These collaborations have further enriched his experience and fostered an environment of innovation within their team.

Conclusion

Srinivas Reddy Sanikommu's contributions to the field of pharmaceuticals, particularly through his patent for rivaroxaban, showcase his dedication to advancing medical science. His ongoing work at Glenmark Pharmaceuticals Limited highlights the importance of innovation in developing effective healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…